Effects of 5-HT_5A receptor blockade on amnesia or forgetting

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Previous studies indicated SB-699551's effects on memory consolidation and its pro-cognitive efficacy in a ketamine-induced schizophrenia model.
• The 5-HT5A receptor antagonist SB-699551 has shown differential effects on short-term (STM) and long-term memory (LTM) in autoshaping tasks.

Purpose of the Study:

• To compare the efficacy of lever-press versus nose-poke operanda in an autoshaping task for improving conditioned responses (CR).
• To investigate the effects of SB-699551 on memory retention, specifically its ability to prevent forgetting and amnesia.
• To explore the potential reversal of amnesic effects induced by SB-699551 through co-administration with other receptor antagonists.

Main Methods:

• Autoshaping task comparing lever-press and nose-poke responses in rodents.
• Administration of SB-699551 at varying doses (0.1-3.0 mg/kg) post-training.
• Induction of forgetting via a 1-week training interruption and amnesia using dizocilpine or scopolamine.
• Assessment of conditioned responses (CR) at different time points (1.5h, 24h, 48h).

Main Results:

• The nose-poke operandum demonstrated reduced inter-individual variance and increased CR, sustained up to 48 hours.
• SB-699551 (0.3 and 3.0 mg/kg) significantly prevented forgetting after a 1-week interruption in training.
• SB-699551 (0.3 mg/kg) induced amnesia-like effects, which were reversed by co-administration with dizocilpine or scopolamine.

Conclusions:

• The nose-poke operandum is a reliable tool for enhancing and sustaining conditioned responses in memory studies.
• Low doses of 5-HT5A receptor antagonists, like SB-699551, show promise in mitigating memory deficits associated with forgetting and amnesia.
• Further research is warranted to elucidate the precise anti-amnesic and anti-forgetting mechanisms of SB-699551.